TAO Synergies Inc. (TAOX)

TAO Synergies Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

TAO Synergies Inc. (TAOX) is a Biotechnology company based in US with a market capitalization of $14M. Free cash flow was negative at -$6.4M. This page tracks TAOX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 4 employees · IPO Jul 2, 2025

Valuation

Valuation & price

$5.22as of May 17, 2026· -49.7% vs 52w high

P/E ratio

Latest-FY diluted EPS

0.64

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$9.69$6.54$3.39Jul 25Dec 25Jul 26
$3.3552-week range$10.38
Loading valuation history…

Fundamentals

Key fundamentals

$14M

Market cap

Revenue growth (YoY)

100.0%

Gross margin

-$6.4M

Free cash flow (USD)

-$5.5M

Net debt

Net cash position

66.7%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20212025

$0$299.1K

Free cash flow by year

20212025

-$8.7M-$6.4M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 3, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportJun 5, 2026Filing

    10-K Filed

  • Quarterly reportMay 13, 2026Filing

    10-Q Filed

Questions

Frequently asked questions

What is TAO Synergies Inc.'s market cap?

TAO Synergies Inc. (TAOX) has a market capitalization of $14M.

What is TAOX's P/E ratio?

A meaningful P/E ratio is not available for TAOX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is TAOX's price-to-book (P/B) ratio?

TAOX trades at 0.64 times book value per share.

When did TAO Synergies Inc. last report earnings?

TAOX last reported earnings on June 3, 2026; the next date is not yet scheduled.

Are insiders buying TAOX stock?

SEC Form 4 filings show no open-market insider buys at TAO Synergies Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.